Zealand Pharma (ZLDPF) shareholders start the obesity test

[ad_1]

Weight and fitness control for a healthy life

Cunaplus_M.Faba / iStock via Getty Images

  • Zealand Pharma shares (OTCPK: ZLDPF) Denmark Biotech, the first participant’s obstructive therapy Petrelintide announced the medium-stage trial for obesity therapy, the subject of the company’s recent license

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *